EDITORIAL

The challenge of evaluating of SARS-CoV-2 antibody responses among vaccinated transplant patients

Taito Kitano

orcid.org/0000-0003-0623-066X

Division of Infectious Diseases, Department of Paediatrics, Hospital for Sick Children, University of Toronto, Toronto, Ontario, Canada

Department of Health Policy and Management, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA

Search for more papers by this author

Aaron Campigotto,

Aaron Campigotto

Department of Paediatric Laboratory Medicine, Hospital for Sick Children, University of Toronto, Toronto, Ontario, Canada

Search for more papers by this author

Upton Allen,

Corresponding Author

Upton Allen

[email protected]

orcid.org/0000-0002-2326-7731

Division of Infectious Diseases, Department of Paediatrics, Hospital for Sick Children, University of Toronto, Toronto, Ontario, Canada

Correspondence

Upton Allen, Division of Infectious Diseases, Hospital for Sick Children, 555 University Ave, Toronto, ON, Canada M5G 1X8.

Email: [email protected]

Search for more papers by this author

Taito Kitano,

Taito Kitano

orcid.org/0000-0003-0623-066X

Division of Infectious Diseases, Department of Paediatrics, Hospital for Sick Children, University of Toronto, Toronto, Ontario, Canada

Department of Health Policy and Management, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA

Search for more papers by this author

Aaron Campigotto,

Aaron Campigotto

Department of Paediatric Laboratory Medicine, Hospital for Sick Children, University of Toronto, Toronto, Ontario, Canada

Search for more papers by this author

Upton Allen,

Corresponding Author

Upton Allen

[email protected]

orcid.org/0000-0002-2326-7731

Division of Infectious Diseases, Department of Paediatrics, Hospital for Sick Children, University of Toronto, Toronto, Ontario, Canada

Correspondence

Upton Allen, Division of Infectious Diseases, Hospital for Sick Children, 555 University Ave, Toronto, ON, Canada M5G 1X8.

Email: [email protected]

Search for more papers by this author

First published: 26 May 2022

https://doi.org/10.1111/petr.14319

All authors meet the ICMJE authorship criteria.

Share a link

Email
Wechat
Bluesky

No abstract is available for this article.

CONFLICT OF INTEREST

All authors declare that they have no conflicts of interest related to this study.

Open Research

DATA AVAILABILITY STATEMENT

Data sharing is not applicable to this article as no new data were created or analyzed in this study.

REFERENCES

1Feingold B, Berman P, Moninger A, et al. Responsiveness to second and third dose of mRNA COVID-19 vaccination in adolescent and young adult heart transplant recipients [published online ahead of print, 2022 Mar 27]. Pediatr Transplant. 2022; e14272. doi:10.1111/petr.14272
10.1111/petr.14272
PubMed Web of Science® Google Scholar
2 Centers for Disease Control and Prevention. Interim clinical considerations for use of COVID-19 vaccines currently approved or authorized in the United States. https://www.cdc.gov/vaccines/covid-19/clinical-considerations/covid-19-vaccines-us.html. Accessed on Mar 8, 2022.
Google Scholar
3Muruato AE, Fontes-Garfias CR, Ren P, et al. A high-throughput neutralizing antibody assay for COVID-19 diagnosis and vaccine evaluation [published correction appears in Nat Commun. 2021 Jun 22;12(1):4000]. Nat Commun. 2020; 11(1): 4059 Published 2020 Aug 13. doi:10.1038/s41467-020-17892-0
10.1038/s41467-020-17892-0
CAS PubMed Web of Science® Google Scholar
4Khoury DS, Cromer D, Reynaldi A, et al. Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection. Nat Med. 2021; 27(7): 1205-1211. doi:10.1038/s41591-021-01377-8
10.1038/s41591-021-01377-8
CAS PubMed Web of Science® Google Scholar
5Earle KA, Ambrosino DM, Fiore-Gartland A, et al. Evidence for antibody as a protective correlate for COVID-19 vaccines. Vaccine. 2021; 39(32): 4423-4428. doi:10.1016/j.vaccine.2021.05.063
10.1016/j.vaccine.2021.05.063
CAS PubMed Web of Science® Google Scholar
6Goldblatt D, Fiore-Gartland A, Johnson M, et al. Towards a population-based threshold of protection for COVID-19 vaccines. Vaccine. 2022; 40(2): 306-315. doi:10.1016/j.vaccine.2021.12.006
10.1016/j.vaccine.2021.12.006
CAS PubMed Web of Science® Google Scholar
7 Centers for Disease Control and Prevention. Interim guidelines for COVID-19 antibody testing. https://www.cdc.gov/coronavirus/2019-ncov/lab/resources/antibody-tests-guidelines.html. Accessed on Mar 8, 2022.
Google Scholar
8Cappuccilli M, Bruno PF, Spazzoli A, et al. Persistence of antibody responses to the SARS-CoV-2 in dialysis patients and renal transplant recipients recovered from COVID-19. Pathogens. 2021; 10(10): 1289. Published 2021 Oct 6. doi:10.3390/pathogens10101289
10.3390/pathogens10101289
CAS PubMed Web of Science® Google Scholar
9Weisberg SP, Connors TJ, Zhu Y, et al. Distinct antibody responses to SARS-CoV-2 in children and adults across the COVID-19 clinical spectrum. Nat Immunol. 2021; 22(1): 25-31. doi:10.1038/s41590-020-00826-9
10.1038/s41590-020-00826-9
PubMed Web of Science® Google Scholar
10Bertrand D, Lemée V, Laurent C, et al. Waning antibody response and cellular immunity 6 months after third dose SARS-Cov-2 mRNA BNT162b2 vaccine in kidney transplant recipients [published online ahead of print, 2022 Jan 10]. Am J Transplant. 2022; 22: 1498-1500. doi:10.1111/ajt.16954
10.1111/ajt.16954
CAS PubMed Web of Science® Google Scholar

Volume26, Issue6

September 2022

e14319

The challenge of evaluating of SARS-CoV-2 antibody responses among vaccinated transplant patients

CONFLICT OF INTEREST

Open Research

DATA AVAILABILITY STATEMENT

REFERENCES

References

Information

About Wiley Online Library

Help & Support

Opportunities

Connect with Wiley

The challenge of evaluating of SARS-CoV-2 antibody responses among vaccinated transplant patients

This article relates to:

Responsiveness to second and third dose of mRNA COVID-19 vaccination in adolescent and young adult heart transplant recipients

CONFLICT OF INTEREST

Open Research

DATA AVAILABILITY STATEMENT

REFERENCES

References

Related

Information